Residency Program Director
  • Lynn Wardlow, PharmD, MBA, MS, BCPS, BCIDP, AAHIVP

    • Infectious Diseases Residency Program Director
    • Specialty Practice Pharmacist, Infectious Diseases
    • PGY1 Pharmacy Practice Residency - University of Arizona
    • PGY2 Infectious Diseases Residency - University of California-San Diego
Previous Year Residents
  • Bradley Taranto, PharmD

    Antimicrobial Stewardship Pharmacist - Mount Carmel East
  • Allison Cid, PharmD

    OPAT/Antimicrobial Stewardship Pharmacist, FirstHealth Moore Regional Hospital
  • Lindsey Groff

    Clinical Pharmacy Specialist in Infectious Diseases University Hospital (UT Health San Antonio), San Antonio, TX
  • Ashley Lorenz

    Pharmacy Clinical Specialist, Infectious Diseases, Cleveland Clinic Fairview
  • Amy Parks Taylor

    Clinical Pharmacist, Memorial Health University Medical Center, Savannah, Georgia
  • Megan Shah

    ID/AST Pharmacist, University of Virginia
  • Lauren Hunt

    Director, Antimicrobial Stewardship-East at bioMérieux, Inc
  • Pavithra Srinivas

    MSL, Infectious Diseases & Vaccines, Janssen Pharmaceuticals
  • Derek Bremmer

    Clinical Pharmacy Specialist - Infectious Diseases / Antimicrobial Stewardship- Allegheny General Hospital

Interested in our PGY2 Infectious Disease Program?

Please sign up for a 1 on 1 discussion to learn more

We are offering 30 minute virtual 1 on 1 discussions to learn more about our PGY2 Infectious Disease Program. Please fill out our survey via the link or QR Code below and someone will reach out to you.


QR Code:

About the PGY2 Infectious Diseases Residency Program


PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Pharmacists completing this residency will have a well-rounded experience involving the care of medical, surgical, and immunocompromised patients. The program is designed to develop the resident’s clinical expertise in infectious diseases and provide opportunities for research, didactic teaching and layered preceptorship, and participation in a comprehensive Antimicrobial Stewardship Program The goal of the program is to develop as an independent practitioner and to become an integral member of an infectious diseases multidisciplinary team and Antimicrobial Stewardship Program. Additionally, following completion of this program, the resident will be prepared to obtain a clinical faculty appointment at a college of pharmacy or university.

Residency Sites

The Ohio State University Wexner Medical Center (OSUWMC) is a 1,506 bed tertiary care medical center located in Columbus, Ohio. It is a multi-hospital delivery system recognized in 2018 as one of “America’s Best Hospitals” for excellence in ten specialties by US News and World Report based on quality, outcomes, and reputation. We are proud that we have one of the largest antimicrobial stewardship programs in the country and are focused on complete disease state management of patients with an emphasis on the use of rapid diagnostic testing.

Read about the sites

University Hospital (UH)

University Hospital (UH) is our flagship hospital with over 900 beds. UH is a major referral center for patients throughout Ohio and the Midwest, and is one of the busiest kidney and pancreas transplant centers in the world. UH is also an international center for neuromodulation research and neurological care. In addition, UH is a level 1 trauma center in addition to being the American Burn Associated verified adult burn center for the region.

The James Cancer Hospital and Solove Research Institute

The James Cancer Hospital and Solove Research Institute is one of the nation’s premier centers for the prevention, detection and treatment of cancer. OSUWMC features the world’s most advanced cancer and critical care hospital which opened in December of 2014.

With the opening of the new hospital, our institution boasts an Emergency Department (ED) with over 100 beds and an area dedicated specifically to the care of cancer patients within the ED. Medical Intensive Care, Surgical Intensive Care, Neuro Intensive Care, and Cancer specific ICU patient care areas also exist within the new critical care tower. Between UH and the new ICUs within the James Cancer Hospital, the Medical Center has 4 Medical ICU services, 3 Surgical ICU services, and 1 Neurocritical Care service totaling over 100 ICU beds.

The Ross Heart Hospital

The Ross Heart Hospital is a leader in cardiology and heart surgery and is the only nationally ranked heart hospital in the area. Each floor of the 150-bed hospital is dedicated to a specific service, which helps us provide specialized care for every patient. The Ross is one of the largest centers for the implantation of LVAD devices in the world in addition to providing heart and lung transplants.

University Hospitals East (UHE)

University Hospitals East (UHE) blends the friendly atmosphere of a community hospital with the advantages of being a part of a major academic medical center. Located on the eastern edge of downtown Columbus, University Hospital East offers renowned Ohio State services in orthopedic care, emergency services, cancer care, addiction services, ear, nose and throat care, heart care, radiology and imaging services, rehabilitation and wound healing. University Hospital East has a 19 bed mixed medical/surgical ICU.

The Brain and Spine Hospital

The Brain and Spine Hospital opened in the  in Fall  of 2016 and is a state-of-the-art facility for the advanced management, care and healing of patients with neurological disorders.The hospital consists of 87 private beds and specialized units for stroke and neurovascular, neurotrauma, epilipsy, spine, chronic pain, neuromodulaton, multiple sclerosis, congnitive and movement disorders, as well as an innovative new model for acute spinal cord injuries.

The Department of Pharmacy

The Department of Pharmacy at The OSUWMC is one of the largest in the country. With over 400 employees, and a practice model that includes both clinical pharmacy generalists and clinical pharmacy specialists, our goal is the provision of outstanding, state of the art care. We advise our staff on the best use of medications, develop safeguards for our patients to prevent medication errors and develop transformative pharmacy practice in health-systems. We are guided in this mission by our strategic plan that focuses on five key priorities: optimizing our pharmacy information system, refining our practice model, enhancing our medication safety program, establishing the pharmacy as a workplace of choice in Central Ohio and refining our academic relationships and department scholarship.

Training future generations of pharmacists is a vital part of our mission. Our pharmacists serve as preceptors for our residency programs while providing experiential training for Doctor of Pharmacy (PharmD) students. Our residency program has a 55-year tradition of excellence with our graduates being well-prepared to work at a high-level in a wide-variety of institutional and ambulatory patient care facilities.

The Department of Pharmacy, in partnership with the Ohio State College of Pharmacy, strives to develop the skills of our residents and provide a residency program that is recognized nationally for the quality and excellence of its graduates.

Key rotations/experiences

The twelve month residency allows the resident to increase clinical knowledge and skills in infectious diseases through a variety of practice sites, including the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, one of the nation’s premier centers for the prevention, detection, and treatment of cancer, and the Richard M. Ross Heart Hospital, a national leader in cardiology and heart surgery.

Read More

The ID residency program offers the resident the benefit of selecting a unique combination of rotations, including any of six infectious diseases consult services. These services care for diverse patient populations including: internal medicine (medical and surgical), critical care (emergency medicine, medical, surgical, and neuro), cardiovascular, bone marrow transplant, hematology/oncology, and solid organ transplant (heart, lung, liver, kidney, and kidney-pancreas). In addition, the ID resident is an integral member of the Antimicrobial Stewardship Program consisting of ID physicians, pharmacists, microbiologists, infection preventionists, epidemiologists, nurses, and a data manager. The resident will participate in stewardship activities throughout the year, including on-call antimicrobial approval pager coverage, Antibiotic Subcommittee attendance, and the potential for developing ASP within the Ohio State Health Network.

Required experiences in the following areas:

  • Learning Experience Duration Per Rotation
    Orientation 1 – 5 weeks
    Adult General Infectious Disease Consult Service I* 4 – 5 weeks
    Adult General Infectious Diseases Consult Service II* 4 – 5 weeks
    Adult General Infectious Diseases Consult Service III* 4 – 5 weeks
    Adult Immunocompromised Infectious Diseases Consult Service –

    Solid Organ Transplant*

    4 – 5 weeks
    Adult Immunocompromised Infectious Diseases Consult Service – Hematology/Oncology* 4 – 5 weeks
    Clinical Antimicrobial Stewardship* 4 – 5 weeks
    Antimicrobial Stewardship Program Administration* 2 – 3 weeks
    Clinical Microbiology Laboratory* 2 – 3 weeks
    OSU Infectious Diseases HIV Clinic 1 year (Longitudinal)
    Infectious Diseases Clinical Teaching (Precepting) 1 year (Longitudinal)
    Infectious Diseases Didactic Teaching 1 year (Longitudinal)
    Clinical and Operational Staffing 1 year (Longitudinal)
    Infectious Diseases Research 1 year (Longitudinal)
    Quality and Leadership within Infectious Diseases 1 year (Longitudinal)

Required rotations may be repeated depending on resident interest.

*Denotes a core, required learning experience.

Elective experiences 2-4 weeks in length include, but are not limited to:

  • Learning Experience Duration Per Rotation
    Abdominal Transplant 2 – 5 weeks
    Adult Immunocompromised Infectious Diseases Consult Service – Hematology/Oncology II* 2 – 5 weeks
    Burn Service 2 – 5 weeks
    Clinical Antimicrobial Stewardship II 2 – 5 weeks
    Critical Care 2 – 5 weeks
    Emergency Medicine 2 – 5 weeks
    Hematology 2 – 5 weeks
    OSU Infectious Diseases HIV Clinic 2 – 5 weeks
    Internal Medicine 2 – 5 weeks
    Outpatient Parenteral Antimicrobial Therapy 2 – 5 weeks
    Pediatric Infectious Diseases 2 – 5 weeks
    The Ohio State Health Network Antimicrobial Stewardship Outreach Program 2 – 5 weeks
    Thoracic Transplant 2 – 5 weeks
    University Hospital East Consult Service I 2 – 5 weeks
    University Hospital East Consult Service II 2 – 5 weeks

Teaching Experience

The resident will serve as a preceptor for PharmD students through the layered learning model, assist in facilitating team based learning and presenting didactic lectures at The Ohio State University College of Pharmacy, provide education to other healthcare professionals, and participate in other teaching activities.  The resident will have the option to participate in the teaching certificate program in collaboration with the College of Pharmacy.

Key Preceptors

Natalie Nielsen, PharmD, BCACP,
HIV Clinic

Erica Reed, PharmD, BCPS, BCIDP
View Profile

Infectious Diseases/Antimicrobial Stewardship

Jessica Smith, PharmD, MBA, BCIDP
View Profile

Infectious Diseases/Antimicrobial Stewardship

Lynn Wardlow, PharmD, MBA, MS, BCPS, BCIDP, AAHIVP
View Profile

Infectious Diseases/Antimicrobial Stewardship

Nikki Tran, PharmD, BCIDP
View Profile

Infectious Diseases/Antimicrobial Stewardship

PGY2 Infectious Diseases Recruitment Video

selected resident research

The resident will participate in and complete a clinical research project. The resident will work closely with clinicians who have extensive research experience. More information about research-related support offered can be found here. The resident’s major research project will be presented at a select pharmacy conference, will be submitted at publication, and may be submitted to a national or international infectious diseases conference. Additional opportunities exist for a microbiology project or quality improvement initiative. The resident may also attend IDWeek or the Making a Difference in Infectious Diseases (MAD-ID) meeting.

  • Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk. Pharmacotherapy. 2022;42(12):880-889. -Cid A, Smetana ME, Hebert C, Coe K, Smith JM.
  • Clinical outcomes of combination versus monotherapy for gram negative non-HACEK infective endocarditis. Diag Microbiol Infect Dis. 2021;101(3):115504. –Lorenz A, Sobhanie MM, Orzel L, Coe K, Wardlow L.
  • Safety outcomes with high-dose daptomycin in patients with acute kidney injury and/or end-stage renal disease. J Clin Pharm Ther. 2021;46(2):363-368. –Vlashyn OO, Lorenz AM, Sobhanie MM, Smith JM, Bond M, Wardlow L.
  • Clinical impact of an antibiotic time out initiative at an academic medical center. Hospital Pharmacy. 2021;56(4):343-346. –Taylor AP, Coe K, Stevenson K, Wardlow L, El Boghdadly Z, Reed E
  • Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia. J Antimicrob Chemother. 2019;74(1):2055-2059. – Shah MD, Coe KE, El Boghdadly Z, Wardlow LC, Dela-Pena JC, Stevenson KB, Reed EE.
  • Community-acquired carbapenem-resistant Serratia marcescens endocarditis: a case report. J Clin Case Rep. 2018;1(2):1011. – Shah MD, Reed EE, Mangino JE.

Benefits and Additional Requirements

This program will be going through the 2023 ASHP Match and participating in virtual interviews. Information about application requirements can be found here.

Application Deadline:  January 4, 2023

We welcome applications from non-U.S. citizens who have a “green card” (permanent resident status) or a current visa valid through the entire duration of the residency program. The Ohio State University pharmacy residency programs are NOT able to sponsor visas for pharmacy residents (PGY1 or PGY2).

Start Date: July 1

Annual Salary – $50,500

Vacation Days – 10 days

Staffing Requirement – 20 weekends per year

Completion of a Major Research Project


Download PDF

Residency wellness is supported through the ResiSHINE (Support Health Initiatives and Nurture Excellence) Committee. Additional information can be found here.